QualityStocksNewsBreaks Archives - Page 707 of 1274

WednesdayOct 07, 2020 10:27 am

QualityStocksNewsBreaks – Exro Technologies Inc. (TSX.V: EXRO) (OTCQB: EXROF) Achieves ‘Amazing Breakthrough’ in Electric Bike Technology, Micro-Mobility Applications

Exro Technologies (TSX.V: EXRO) (OTCQB: EXROF), a leading technology company that has developed a new class of power electronics for electric motors and powertrains, today announced that third-party testing has proven its patented Coil Driver technology dramatically improves performance of electric bikes. According to the update, Vancouver-based Motorino Electric, a manufacturer and distributor of electric bikes and motorcycles, completed field testing of Exro's technology through 2020 against a standard electric bike. Testing found a more than 20% performance increase, and up to 50% in climbing conditions, of the Exro-enhanced electric bike. Exro will now start negotiations on a commercial product…

WednesdayOct 07, 2020 10:22 am

QualityStocksNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Closing of Public Offering

Processa Pharmaceuticals (NASDAQ: PCSA) has closed its previously announced underwritten public offering of 4,800,000 shares of common stock, which were offered to the public for $4 per share. The clinical-stage biopharmaceutical company, which focuses on the development of drug products intended to provide treatment for and improve the survival and/or quality of life of patients who have a high unmet medical need condition or who have no alternative treatment, announced that the public offering resulted in gross proceeds of approximately $19.2 million. PCSA has filed a registration statement relating to the securities being sold with the Securities and Exchange Commission (“SEC”);…

WednesdayOct 07, 2020 9:50 am

QualityStocksNewsBreaks – 180 Life Sciences Corp. Continues to Broaden Global IP Portfolio, Expand Internal Pipeline

KBL Merger Corp. (NASDAQ: KBLM) (KBL Merger Corp. Rights NASDAQ: KBLMR) (KBL Merger Corp. Warrant NASDAQ: KBLMW), a Special Purpose Acquisition Corporation (SPAC) that previously entered a definitive agreement to acquire 180 Life Sciences, a clinical-stage biotechnology company, on Tuesday announced continued expansion of 180 Life Sciences’ robust intellectual property (“IP”) portfolio. According to the update, 180 Life Sciences is an applicant and licensee of a broad and growing patent portfolio for three major drug platforms in the areas of inflammation, fibrosis and pain. The portfolio covers 14 patent families with 42 patents issued and 32 pending in several important…

TuesdayOct 06, 2020 1:25 pm

QualityStocksNewsBreaks – The Alkaline Water Company Inc.’s (CSE: WTER) (NASDAQ: WTER) A88 Infused(TM) Grabbing Shelf Space in Trend Expected to Accelerate

The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, today announced that its A88 Infused(TM) brand is gaining ground in the fast-growing flavored water market. According to the update, A88 Infused flavored water is widely available through multiple channel partners across various trades. “Demand for our single-serve offerings are at an all-time high, and we are rapidly growing shelf space for our A88 Infused flavored waters,” WTER president and CEO Ricky Wright said in the press release. “Our channel partners are some of the leading players in the…

TuesdayOct 06, 2020 12:51 pm

QualityStocksNewsBreaks – Predictive Oncology (NASDAQ: POAI) Shareholder Letter Provides Company Update, Status of Subsidiaries

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has released a shareholder letter providing a review of where POAI “stands as of today.” The letter noted that, despite a decline of stock price over the past few weeks, the company’s cash burn is stable and even trending down, and revenues are stable and trending upward. The letter notes that POAI has adequate cash for operation, as well as ability to utilize an equity line of credit of more than $10 million. The letter also provides an update on the…

TuesdayOct 06, 2020 12:08 pm

QualityStocksNewsBreaks – Kaival Brands Innovations Group Inc. (KAVL) Engages IBN to Maximize Communication, Refine Messaging and Outreach

Kaival Brands (OTCQB: KAVL), a company focused on growing and incubating innovative and profitable products into mature, dominant brands, today announced it has selected the corporate communications expertise of the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. Kaival promotes innovative brand solutions and is the exclusive global distributor for Bidi(TM) Stick, an offering made from high-quality components and equipped with a long-lasting battery and class A nicotine. The company recently entered an agreement through which it will acquire exclusive rights to an international patent portfolio concerning full customization of certain isomeric properties of…

TuesdayOct 06, 2020 12:02 pm

QualityStocksNewsBreaks – Grey Cloak Tech Inc. (GRCK) Launches New Product Designed to Boost Immune System

Grey Cloak Tech (OTC: GRCK), through its subsidiary BergaMet NA, has introduced Clinical IMMUNE(TM), a concentrated nutraceutical supplement formulated with naturally grown, heart-healthy Citrus Bergamot SuperFruit(TM), BetaVia(TM) Complete, and nine other powerful immune-boosting ingredients. The company is calling the product the No. 1 immune system defense for the body. Clinical IMMUNE contains natural ingredients, is GMO-free, and has been scientifically formulated to reduce upper respiratory symptoms, strengthen the body’s immune system, and maintain healthy blood sugar and blood pressure. The product also works to support a healthy cardiovascular system and address infectious conditions. Clinical IMMUNE offers two immune-building ingredients not found…

TuesdayOct 06, 2020 11:33 am

QualityStocksNewsBreaks – Pressure BioSciences (PBIO) Locks In Final System Design, Begins Production of Alpha Unit

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, and other industries, has reached what it calls as a critical milestone. The company announced the lock-in of final design specifications for the commercial production model of its proprietary, next-generation Ultra Shear Technology(TM)-based nanoemulsification system. In addition, PBIO has begun initial commercial system development of the system. Once the alpha unit has been tested and approved, the company will begin building an additional 15 ready-for-sale systems. This strategy aligns with PBIO’s objective of shipping…

TuesdayOct 06, 2020 11:33 am

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Present at Cell and Gene Therapy Sector’s Foremost Annual Conference

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for cancer and diabetes patients, today announced that it will present at the Alliance for Regenerative Medicine’s (“ARM”) virtual Cell and Gene Meeting on the Mesa, which is set to take place October 12-16, 2020. Genprex’s executive vice president and COO Michael Redman will lead the company’s presentation. The 2020 event will be delivered in a virtual format over the course of five days and feature on-demand company presentations and live-streaming panels. The Cell and Gene Meeting on the Mesa is the sector’s foremost annual conference, bringing together…

Site Search

Company Search

Category: QualityStocksNewsBreaks